How many insider declarations has Versant Vantage I, L.P. filed?

Versant Vantage I, L.P. has filed 7 public insider declarations with SEC (Form 4).

What is Versant Vantage I, L.P.'s role?

Versant Vantage I, L.P.'s reported role is not specified by the regulator across the filings.

Which companies does Versant Vantage I, L.P. report trades for?

Versant Vantage I, L.P. reports trades for Repare Therapeutics Inc..

What is Versant Vantage I, L.P.'s declared buy vs sell volume?

Across the available history, declared buys total 0 and disposals 2.8M€.

← Executives ★ Sign in to follow

VV

Versant Vantage I, L.P.

Other

US·SEC (Form 4)

Repare Therapeutics Inc.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

€3m

▼ Sales (1 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

1

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Explore the full record of transactions filed by Versant Vantage I, L.P.. Officer active across 1 company, notably Repare Therapeutics Inc.. Cumulatively, 7 filings have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €2.8m. Activity tracked since 5 May 2021. The latest transaction was filed on 3 June 2022 (Cession). Regulator: SEC (Form 4). The full history is openly available.

Declarations7 total

▼

Versant Vantage I, L.P.

Executives3 Jun 2022Repare Therapeutics Inc.

$3M25SEC ↗

250,000 shares@ US$12.2517100.0% of flowCommon SharesSEC:0000899243-22-021350:0

●

Versant Vantage I, L.P.

Executives5 Aug 2021Repare Therapeutics Inc.

2SEC ↗

152,071 shares0Common SharesSEC:0000899243-21-032172:0

●